RMRobert J. McConnell

Robert J. McConnell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Robert J. McConnell has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Data from Radiation Risk of Screening-Detected Diffuse Goiter in a Belarusian Cohort Exposed as Children or Adolescents to Iodine-131 after Chernobyl

    by Lydia B. Zablotska, Robert J. McConnell, Aleksandr V. Rozhko, Patrick O’KAne, Vasilina Yauseyenka, Mark P. Little, Viktor Minenko, Vladimir V. Drozdovitch, Olga V. Parhomenko, Maureen Hatch, et al.

    Background:We previously reported a significantly increased risk of thyroid cancer due to radioactive iodine-131 after the 1986 Chernobyl nuclear accident in a cohort of children and adolescents from Belarus. Radiation-related cancer risks were five times higher among those with diffuse goiter; however, the relationship between radiation dose and diffuse goiter is not well understood. Methods:We used logistic regression to analyze data from 10,278 study participants [mean thyroid dose = 0.63 gray (Gy)] who were screened 10 to 15 years after exposure according to a standardized protocol, which specified thyroid size assessment by both ultrasound and palpation. Results:Diffuse goiter was identified in 1,811 subjects and was significantly associated with 131I dose (P < 0.001). The linear model provided the best fit to the data at doses <0.5 Gy [odds ratio (OR) at 1 Gy = 2.45; 95% confidence interval, 1.70–3.41] and linear–exponential model at doses <1.5 Gy (OR at 1 Gy = 1.84). Age at exposure and indicators of iodine deficiency both before the accident (place of residence) and during screening (urinary iodine levels) significantly modified the dose-response (all P values < 0.01). Conclusions:The first systematic evaluation of radiation risks of diffuse goiter after environmental exposure found a strong, statistically significant association with thyroid dose. Impact:Our study shows that radiation exposure is associated with a significantly increased risk of developing diffuse goiter. Future epidemiologic studies of iodine-deficient irradiated populations should assess thyroid size.

  • Open Access

    Supplementary Data Table S1 from Radiation Risk of Screening-Detected Diffuse Goiter in a Belarusian Cohort Exposed as Children or Adolescents to Iodine-131 after Chernobyl

    by Lydia B. Zablotska, Robert J. McConnell, Aleksandr V. Rozhko, Patrick O’KAne, Vasilina Yauseyenka, Mark P. Little, Viktor Minenko, Vladimir V. Drozdovitch, Olga V. Parhomenko, Maureen Hatch, et al.

    Supplementary Data Table S1. Comparison of best-fitting dose–response models for prevalent diffuse goiter, showing odds ratios at 1 Gy, model fit statistics, and adjustments for key covariates, Belarus, 1996 to 2004.

  • Radiation risk of screening-detected diffuse goiter in a Belarusian cohort exposed as children or adolescents to iodine-131 after Chernobyl

    by Lydia B. Zablotska, Robert J. McConnell, Aleksandr V. Rozhko, Patrick O'KAne, Vasilina Yauseyenka, Mark P. Little, Viktor Minenko, Vladimir V. Drozdovitch, Olga V. Parhomenko, Maureen Hatch, et al.

    Background: We previously reported a significantly increased risk of thyroid cancer due to radioactive iodine-131 (131I) after the 1986 Chernobyl nuclear accident in a cohort of children and adolescents from Belarus. Radiation-related cancer risks were five times higher among those with diffuse goiter, but the relationship between radiation dose and diffuse goiter is not well understood. Methods: We used logistic regression to analyze data from 10,278 study participants (mean thyroid dose=0.63 gray (Gy)) who were screened 10-15 years after exposure according to a standardized protocol, which specified thyroid size assessment by both ultrasound and palpation. Results: Diffuse goiter was identified in 1,811 subjects and was significantly associated with 131I dose (P<0.001). The linear model provided the best fit to the data at doses <0.5 Gy (excess odds ratio per gray (EOR/Gy) = 1.45, 95% confidence interval (CI): 0.70, 2.41) and linear-exponential model at doses <1.5 Gy (odds ratio (OR) at 1 Gy = 1.84). Age at exposure and indicators of iodine deficiency both before the accident (place of residence) and during screening (urinary iodine levels) significantly modified the dose-response (all P-values < 0.01). Conclusions: The first systematic evaluation of radiation risks of diffuse goiter after environmental exposure found a strong, statistically significant association with thyroid dose. Impact: Our study shows that radiation exposure is associated with a significantly increased risk of developing diffuse goiter. Future epidemiological studies of iodine-deficient irradiated populations should assess thyroid size.

  • Prevalence of Thyroid Nodules in Residents of Ukraine Exposed as Children or Adolescents to Iodine-131 from the Chornobyl Accident

    by Elizabeth Khaykin Cahoon, Eric Grimm, Kiyohiko Mabuchi, Jim Zhiming Mai, Rui Zhang, Vladimir Drozdovitch, Maureen Hatch, Mark P. Little, Kamau O. Peters, Tetiana I. Bogdanova, et al.

    Background: Although childhood exposure to radioactive iodine-131 (I-131) is an established risk factor for thyroid cancer, evidence for an association with thyroid nodules is less clear. The objective of this study is to evaluate the association between childhood I-131 exposure and prevalence of ultrasound-detected thyroid nodules overall and by nodule histology/cytology (neoplastic/suspicious/non-neoplastic), size (<10 mm/≥10 mm), and number (single/multiple). Methods: This is a cross-sectional study of radiation dose (mean = 0.53 gray, range: 0.0003–31 gray) and screen-detected thyroid nodules conducted in 1998–2000 (median population age 21.5 years) in a cohort of 13,243 residents of Ukraine who were under 18 years at the time of the Chornobyl accident on April 26, 1986. Excess odds ratios per gray (excess odds ratio [EOR]/Gy) and confidence intervals (CIs) were estimated using logistic regression. Results: Among 13,078 eligible individuals, we identified 358 (2.7%) with at least one thyroid nodule. Significantly increased dose–response associations were found for all nodules and nodule groups with doses <5 Gy except individuals with non-neoplastic nodules. Among individuals with doses <5 Gy, the EOR/Gy for neoplastic nodules (5.35; CI: 2.19–15.5) was significantly higher than for non-neoplastic nodules (0.24; CI: 0.07–0.74), but the EOR/Gy did not vary by nodule size or number. Conclusions: Childhood exposure to I-131 is associated with an increased risk of thyroid nodules detected 12–14 years following exposure, and the risk for neoplastic nodules is higher than for non-neoplastic nodules. Analyses of incident thyroid nodules may help clarify dose–response patterns by nodule characteristics and provide insights into thyroid nodule etiology.


  • Abnormal Thyroid Function Test Results in Patients Taking Salsalate

    by Robert J. McConnell

    Objective. —To evaluate how the nonsteroidal anti-inflammatory agent salsalate affects the results of routine thyroid function tests. Design. —In a cohort of patients taking salsalate for various rheumatic conditions, thyroid function tests were performed with patients on and off the drug. Setting. —Primary care of ambulatory patients in a university medical center. Patients. —A convenience sample of 14 euthyroid subjects, none of whom was taking thyroid hormone or other medication recognized to alter thyroid function. Intervention. —Treatment with therapeutic doses of salsalate for a mean period of 44 weeks. Main Outcome Measures. —Serum levels of thyroxine (T4), free T4, thyroid hormone binding ratio, free T4index (the product of T4and the thyroid hormone binding ratio), triiodothyronine, and thyrotropin. Results. —Serum T4dropped from a mean baseline level of 96.7 nmol/L off salsalate to 53.4 nmol/L on it (P<.001), and the free T4index showed a parallel decline from 85.9 to 50.4 (P<.001), with both values falling into the hypothyroid range. Similarly, free T4levels and total triiodothyronine concentrations were low in several patients treated with salsalate. Serum thyrotropin levels declined transiently, falling from a mean of 3.2 to 1.7 mU/L (P<.02) in patients treated for less than 3 weeks. Patients treated for longer periods had levels comparable to baseline. Despite these changes in the thyroid function test results, all subjects remained clinically euthyroid. Conclusion. —Salsalate commonly produces abnormalities in routine thyroid function test results similar to those found in central hypothyroidism. (JAMA. 1992;267:1242-1243)